LSW Institute Lunch and Learn – Protecting Your Breakthroughs: Patent Strategies for Pharma and Biotech

Dr. Jon Cousin develops and executes worldwide patent strategies for life sciences and pharmaceutical companies. Working closely with his clients to understand their business and objectives, Jon helps them build robust, business-focused and diligence-ready patent portfolios. His practice includes developing patent strategies for drug-discovery and clinical programs, life cycle extension strategies, aligning patent and regulatory exclusivities, and Orange Book listings.

Jon has experience with new chemical entities, peptide therapeutics, polymorphs, formulations, 505(b)(2) products, antibody-drug conjugates, natural products, drug-device combos, biomaterials and manufacturing processes. Notable patent portfolios Jon has advised on include Epidiolex, Copiktra, Farydak, Arikayce, Amrix, Lamictal and Evekeo ODT, along with numerous candidates in clinical trials.

Dr. Carol Laherty focuses her practice on formulating and executing patent and market exclusivity strategies consistent with biotechnology and pharmaceutical companies’ business goals. She has extensive experience in strategic patent counseling and patent portfolio management, preparation and worldwide prosecution of patent applications, intellectual property due diligence, freedom to operate analyses and legal opinions. In addition, Carol counsels investors and companies with respect to intellectual property issues related to potential investments, acquisitions and licensing and partnering opportunities.

Carol has experience in a wide range of technologies, including cellular and molecular biology, immunology, polypeptide and polynucleotide therapeutics, therapeutic antibodies, recombinant vaccines, gene therapy, stem cell therapeutics, diagnostics, drug formulations, drug delivery systems and cleantech biotechnologies.